Industry Comments Show Support For MCIT Proposed Rule – With Reservations

AdvaMed, MDMA strongly back the Medicare coverage proposal, but want agency to back off codifying a definition for ‘reasonable and necessary’

 
• By Sue Darcey

Industry groups were cool to parts of the CMS’s proposed Medicare Coverage of Innovative Technology (MCIT) rule dealing with commercial insurance coverage, as well as definitions used in the proposal.

White transparent skeleton leaf with beautiful texture on a turquoise abstract background on glass with shiny water dew drops
Industry wants the Medicare agency to be more transparent with stakeholders about any new definition of “reasonable and necessary” applied in its MCIT proposal

More from Policy & Regulation

More from Medtech Insight